Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Authors
Keywords
Triple-negative breast cancer, Patient-derived xenograft, Mammosphere, Chemoresistance
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-07
DOI
10.1186/s12885-019-5401-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
- (2018) Tia H. Turner et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting triple negative breast cancer with histone deacetylase inhibitors
- (2017) Palma Fedele et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Three-dimensional cell culture models for anticancer drug screening: Worth the effort?
- (2017) Eddy-Tim Verjans et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Current status and perspectives of patient-derived xenograft models in cancer research
- (2017) Yunxin Lai et al. Journal of Hematology & Oncology
- Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
- (2017) Neelima Vidula et al. Oncotarget
- Patient-derived xenograft (PDX) models in basic and translational breast cancer research
- (2016) Lacey E. Dobrolecki et al. CANCER AND METASTASIS REVIEWS
- Preclinical screening methods in cancer
- (2016) RameshBabu Bodla et al. INDIAN JOURNAL OF PHARMACOLOGY
- Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
- (2016) Yoshiya Horimoto et al. PLoS One
- 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
- (2016) Michele Zanoni et al. Scientific Reports
- Three-Dimensional Cell Culture: A Breakthrough in Vivo
- (2015) Delphine Antoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
- (2015) MEIYING JI et al. ONCOLOGY REPORTS
- Three-dimensional in vitro tumor models for cancer research and drug evaluation
- (2014) Xian Xu et al. BIOTECHNOLOGY ADVANCES
- Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
- (2014) Lyndsay V. Rhodes et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncology Drug Discovery: Planning a Turnaround
- (2014) C. Toniatti et al. Cancer Discovery
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin
- (2013) Preeti Shah et al. BREAST CANCER RESEARCH AND TREATMENT
- New cast for a new era: preclinical cancer drug development revisited
- (2013) Grit S. Herter-Sprie et al. JOURNAL OF CLINICAL INVESTIGATION
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progression
- (2012) Guan-Min Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Flow cytometry in cancer stem cell analysis and separation
- (2012) Burkhard Greve et al. CYTOMETRY PART A
- Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
- (2012) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Advances in the preclinical testing of cancer therapeutic hypotheses
- (2011) Giordano Caponigro et al. NATURE REVIEWS DRUG DISCOVERY
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells
- (2010) Gabriel Benton et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk
- (2010) Lyndsay V Rhodes et al. Molecular Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now